SCHEMBL22064732

SCHEMBL22064732

N#Cc1ccc(-c2ccc(-c3cccc4ccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)cc34)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 11/20 0.44
▸ ABCB1 P08183 5/20 0.44
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ CLK4 Q9HAZ1 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ SLC22A12 Q96S37 1/20 0.42
▸ PIM1 P11309 1/20 0.41
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19942082 0.96 ABCG2 (0.47) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL19942219 0.96 ABCG2 (0.47) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL19942212 0.96 ABCG2 (0.47) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL19942199 0.96 ABCG2 (0.47) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL22065423 0.95 ABCG2 (0.46) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL22065314 0.92 ABCG2 (0.41) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL22987162 0.91 ABCG2 (0.45) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL22986975 0.91 ABCG2 (0.45) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL19942106 0.90 CYP1A2 (0.43) ABCG2ABCB1CYP1A2CYP2C19CYP2C9
SCHEMBL19942214 0.90 CYP1A2 (0.43) ABCG2ABCB1CYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, AHR ABCG2 2815/4885ABCB1 2655/4885CYP1A2 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback